Humana AB (publ) Logo

Humana AB (publ)

HUM.ST

(2.0)
Stock Price

36,35 SEK

1.94% ROA

3.81% ROE

14.85x PER

Market Cap.

1.490.174.285,00 SEK

82.99% DER

0% Yield

1.15% NPM

Humana AB (publ) Stock Analysis

Humana AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Humana AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.48x), the stock offers substantial upside potential at a bargain price.

2 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 ROE

The stock's ROE falls within an average range (8.16%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (4.35%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

6 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (1.503) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 DER

The stock is burdened with a heavy load of debt (178%), making it financially unstable and potentially risky for investors.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

Humana AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Humana AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Humana AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Humana AB (publ) Revenue
Year Revenue Growth
2012 2.981.660.000
2013 3.489.000.000 14.54%
2014 5.065.000.000 31.12%
2015 5.593.000.000 9.44%
2016 6.362.000.000 12.09%
2017 6.542.000.000 2.75%
2018 6.714.000.000 2.56%
2019 7.446.000.000 9.83%
2020 7.771.000.000 4.18%
2021 8.187.000.000 5.08%
2022 9.203.000.000 11.04%
2023 9.632.000.000 4.45%
2023 9.649.000.000 0.18%
2024 10.140.000.000 4.84%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Humana AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Humana AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 187.000.000 100%
2014 393.000.000 52.42%
2015 809.000.000 51.42%
2016 604.000.000 -33.94%
2017 642.000.000 5.92%
2018 679.000.000 5.45%
2019 548.000.000 -23.91%
2020 516.000.000 -6.2%
2021 848.000.000 39.15%
2022 999.000.000 15.12%
2023 0 0%
2023 354.000.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Humana AB (publ) EBITDA
Year EBITDA Growth
2012 211.646.000
2013 257.000.000 17.65%
2014 362.000.000 29.01%
2015 360.000.000 -0.56%
2016 395.000.000 8.86%
2017 371.000.000 -6.47%
2018 453.000.000 18.1%
2019 729.000.000 37.86%
2020 819.000.000 10.99%
2021 926.000.000 11.56%
2022 900.000.000 -2.89%
2023 1.172.000.000 23.21%
2023 457.000.000 -156.46%
2024 1.088.000.000 58%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Humana AB (publ) Gross Profit
Year Gross Profit Growth
2012 376.139.000
2013 3.372.000.000 88.85%
2014 4.819.000.000 30.03%
2015 615.000.000 -683.58%
2016 6.028.000.000 89.8%
2017 6.192.000.000 2.65%
2018 6.375.000.000 2.87%
2019 7.061.000.000 9.72%
2020 7.393.000.000 4.49%
2021 8.128.000.000 9.04%
2022 9.142.000.000 11.09%
2023 9.632.000.000 5.09%
2023 2.119.000.000 -354.55%
2024 516.000.000 -310.66%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Humana AB (publ) Net Profit
Year Net Profit Growth
2012 43.978.000
2013 179.000.000 75.43%
2014 115.000.000 -55.65%
2015 46.000.000 -150%
2016 148.000.000 68.92%
2017 194.000.000 23.71%
2018 245.000.000 20.82%
2019 188.000.000 -30.32%
2020 262.000.000 28.24%
2021 276.000.000 5.07%
2022 210.000.000 -31.43%
2023 328.000.000 35.98%
2023 176.000.000 -86.36%
2024 4.000.000 -4300%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Humana AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 1
2013 3 100%
2014 2 -50%
2015 1 0%
2016 4 100%
2017 4 0%
2018 6 40%
2019 4 -66.67%
2020 5 25%
2021 6 20%
2022 4 -25%
2023 7 33.33%
2023 4 -100%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Humana AB (publ) Free Cashflow
Year Free Cashflow Growth
2012 155.178.000
2013 172.000.000 9.78%
2014 110.000.000 -56.36%
2015 228.000.000 51.75%
2016 -304.000.000 175%
2017 90.000.000 437.78%
2018 158.000.000 43.04%
2019 403.000.000 60.79%
2020 528.000.000 23.67%
2021 582.000.000 9.28%
2022 442.000.000 -31.67%
2023 451.000.000 2%
2023 -34.000.000 1426.47%
2024 111.000.000 130.63%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Humana AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2012 178.597.000
2013 196.000.000 8.88%
2014 156.000.000 -25.64%
2015 274.000.000 43.07%
2016 -161.000.000 270.19%
2017 241.000.000 166.8%
2018 332.000.000 27.41%
2019 631.000.000 47.39%
2020 661.000.000 4.54%
2021 689.000.000 4.06%
2022 633.000.000 -8.85%
2023 621.000.000 -1.93%
2023 -34.000.000 1926.47%
2024 194.000.000 117.53%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Humana AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2012 23.419.000
2013 24.000.000 2.42%
2014 46.000.000 47.83%
2015 46.000.000 0%
2016 143.000.000 67.83%
2017 151.000.000 5.3%
2018 174.000.000 13.22%
2019 228.000.000 23.68%
2020 133.000.000 -71.43%
2021 107.000.000 -24.3%
2022 191.000.000 43.98%
2023 170.000.000 -12.35%
2023 0 0%
2024 83.000.000 100%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Humana AB (publ) Equity
Year Equity Growth
2012 628.484.000
2013 853.000.000 26.32%
2014 986.000.000 13.49%
2015 1.093.000.000 9.79%
2016 1.726.000.000 36.67%
2017 1.891.000.000 8.73%
2018 2.147.000.000 11.92%
2019 2.306.000.000 6.9%
2020 2.354.000.000 2.04%
2021 2.553.000.000 7.79%
2022 2.739.000.000 6.79%
2023 2.910.000.000 5.88%
2023 2.925.000.000 0.51%
2024 3.152.000.000 7.2%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Humana AB (publ) Assets
Year Assets Growth
2012 1.737.369.000
2013 2.196.000.000 20.88%
2014 3.660.000.000 40%
2015 3.838.000.000 4.64%
2016 4.960.000.000 22.62%
2017 5.060.000.000 1.98%
2018 5.218.000.000 3.03%
2019 8.231.000.000 36.61%
2020 8.044.000.000 -2.32%
2021 9.002.000.000 10.64%
2022 9.806.000.000 8.2%
2023 9.760.000.000 -0.47%
2023 10.029.000.000 2.68%
2024 10.650.000.000 5.83%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Humana AB (publ) Liabilities
Year Liabilities Growth
2012 1.108.885.000
2013 1.343.000.000 17.43%
2014 2.674.000.000 49.78%
2015 2.745.000.000 2.59%
2016 3.234.000.000 15.12%
2017 3.169.000.000 -2.05%
2018 3.071.000.000 -3.19%
2019 5.925.000.000 48.17%
2020 5.690.000.000 -4.13%
2021 6.449.000.000 11.77%
2022 7.067.000.000 8.74%
2023 6.850.000.000 -3.17%
2023 7.104.000.000 3.58%
2024 7.498.000.000 5.25%

Humana AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
198.31
Net Income per Share
2.28
Price to Earning Ratio
14.85x
Price To Sales Ratio
0.15x
POCF Ratio
2.71
PFCF Ratio
3.78
Price to Book Ratio
0.55
EV to Sales
0.68
EV Over EBITDA
6.25
EV to Operating CashFlow
10.74
EV to FreeCashFlow
16.74
Earnings Yield
0.07
FreeCashFlow Yield
0.26
Market Cap
1,49 Bil.
Enterprise Value
6,60 Bil.
Graham Number
56.42
Graham NetNet
-123.94

Income Statement Metrics

Net Income per Share
2.28
Income Quality
4.69
ROE
0.04
Return On Assets
0.01
Return On Capital Employed
0.06
Net Income per EBT
0.67
EBT Per Ebit
0.34
Ebit per Revenue
0.05
Effective Tax Rate
0.33

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.05
Operating Profit Margin
0.05
Pretax Profit Margin
0.02
Net Profit Margin
0.01

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
12.49
Free CashFlow per Share
8.02
Capex to Operating CashFlow
0.36
Capex to Revenue
0.02
Capex to Depreciation
0.39
Return on Invested Capital
0.06
Return on Tangible Assets
0.02
Days Sales Outstanding
57.75
Days Payables Outstanding
8.67
Days of Inventory on Hand
-11.31
Receivables Turnover
6.32
Payables Turnover
42.12
Inventory Turnover
-32.29
Capex per Share
4.48

Balance Sheet

Cash per Share
8,02
Book Value per Share
64,14
Tangible Book Value per Share
-34.88
Shareholders Equity per Share
62.08
Interest Debt per Share
56.91
Debt to Equity
0.83
Debt to Assets
0.24
Net Debt to EBITDA
4.84
Current Ratio
0.78
Tangible Asset Value
-1,71 Bil.
Net Current Asset Value
-5,56 Bil.
Invested Capital
8097000000
Working Capital
-0,54 Bil.
Intangibles to Total Assets
0.46
Average Receivables
1,46 Bil.
Average Payables
0,23 Bil.
Average Inventory
-144000000
Debt to Market Cap
1.7

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Humana AB (publ) Dividends
Year Dividends Growth
2017 1
2019 1 0%

Humana AB (publ) Profile

About Humana AB (publ)

Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. It operates through five segments: Individual & Family, Personal Assistance, Elderly Care, Finland, and Norway segments. The Individual & Family segment provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; interim and regular family-based care services; special service housing; outpatient care services; assisted living homes; and specially adapted housing for individuals with functional impairments and special education schools. The Personal Assistance segment offers care services and assistance to individuals with functional impairments. The Elderly Care segment provides elderly care home services. The Finland segment offers individual and family care for children, young people and families with psychiatric diagnoses or psychosocial disorders; special service housing for individuals with functional impairments; elderly care homes; and elderly day care services. The Norway segment provides individual and family care, personal assistance, and special service housing for individuals with functional impairments. The company was founded in 2001 and is headquartered in Stockholm, Sweden.

CEO
Ms. Nathalie Boulas Nilsson
Employee
12.537
Address
Warfvinges väg 39
Stockholm, 112 51

Humana AB (publ) Executives & BODs

Humana AB (publ) Executives & BODs
# Name Age
1 Ms. Nina Marklund Krantz
Director of Human Resources
70
2 Mr. Adam Nerell
Chief Information Officer
70
3 Maria Jansson
Head of Sustainability & Sustainability Manager
70
4 Mr. Hans Dahlgren
Chief Executive Officer of Humana Assistans & Director of Communications
70
5 Ms. Nathalie Boulas Nilsson
President, Chief Executive Officer & Country Manager for Sweden
70
6 Mr. Fredrik Larsson
Executive Officer
70
7 Ewelina Pettersson
Head of Investor Relations
70

Humana AB (publ) Competitors

Attendo AB (publ) Logo
Attendo AB (publ)

ATT.ST

(1.5)
Ambea AB (publ) Logo
Ambea AB (publ)

AMBEA.ST

(3.0)
Inwido AB (publ) Logo
Inwido AB (publ)

INWI.ST

(3.5)
AcadeMedia AB (publ) Logo
AcadeMedia AB (publ)

ACAD.ST

(2.0)
Byggmax Group AB (publ) Logo
Byggmax Group AB (publ)

BMAX.ST

(1.5)